NCT04884035 2026-04-17Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat LymphomaCelgenePhase 1 Recruiting224 enrolled
NCT05169515 2026-03-19A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin LymphomaHoffmann-La RochePhase 1 Recruiting121 enrolled